Improving welfare of farm animals
Vaccines for the protection of farm animals are a main focus of Boehringer Ingelheim’s animal health business activities. Technological progress has significantly enabled Boehringer Ingelheim to generate vaccines with better and more predictable efficacy. This includes the integration of sophisticated molecular biology and the decoding of the genome of target pathogens.
Bovine Viral Dirarrhea (BVD) is one of the major cattle diseases with worldwide distribution. Like any viral disease, BVD is not treatable. Affected animals may suffer severely from the infection, as the disease can cause a variety of clinical symptoms, including immunosuppression (i.e. the reduced activity of the immune system to fight back other pathogens), infertility, abortions and congenital defects in calves. Some animals may develop a more severe condition known as mucosal disease, the result of which is a high mortality rate in affected animals. Boehringer Ingelheim Animal Health offers help for farmers and veterinarians to protect animals infected with Bovine Viral Diarrhea.
Boehringer Ingelheim Animal Health also focuses on the treatment of animals, appropriate therapeutic intervention at the very onset of an emerging case of mastitis is of paramount importance in the successful therapy of mastitis in cattle. Offering solutions to our customers which help reducing pain clearly reflects Boehringer Ingelheim Animal Health´s long-term commitment to improving the health and well-being of farm animals.
Solutions for cattle
Mastitis
Mastitis is the inflammation of the udder in dairy cattle, mainly caused by bacterial infection. Prevention and treatment of mastitis in these animals is key to producing healthy milk and minimising the symptoms associated with this clinical situation. Ubrolexin® and Today® are two products for the treatment of acute bacterial mastitis, whereas Ubrostar® and Tomorrow® are used to prevent mastitis during drying-off in dairy cattle at the end of their lactation period. Mamyzin® is an effective injectable antimicrobial for the treatment of acute mastitis, and Metacam® is used to reduce acute pain associated with this syndrome.
Indications | Brand Names | Active Ingredients | |
---|---|---|---|
Mastitis | Mamyzin® | penethamate hydroiodide | ![]() |
Mastitis |
Ubrostar® Benestermycin® Mamyzin® Secado |
penethamate hydroiodide, framycetin sulphate, benethamine penicillin | ![]() |
Mastitis | Ubrolexin® | cefalexin, kanamycin combination | ![]() |
Mastitis |
Today® Cefa-lak® |
cephapirin sodium | ![]() |
Mastitis |
Tomorrow® Cefa-lak® |
cephapirin benzathine | ![]() |
Pain and inflammatory disorders
Metacam® is a non-steroidal anti-inflammatory drug (NSAID) and addresses the need for maintained profitability and the concern for animal welfare in animal production. Due to its long-acting nature and its outstanding efficacy in controlling inflammatory symptoms, Metacam® helps to minimise losses from inflammation and maintain profitability. At the same time, Metacam® effectively controls pain and supports the restoration of well-being in farm animals. The use of Metacam® is convenient and inflicts minimal stress on animals due to its low-volume, one-shot dosage.
Metacam® is licensed as adjunctive therapy in the treatment of mastitis in lactating cows. In most countries it is also indicated for use in calves affected by diarrhoea and in cattle suffering from respiratory disease.
Indications | Brand Names | Active Ingredients | |
---|---|---|---|
Pain and inflammatory disorders | Metacam® | meloxicam | ![]() |
Infectious diseases
Bovine Viral Diarrhoea Virus (BVDV) is one of the major economically important cattle pathogens with a worldwide distribution. The disease caused by BVDV results in marked production losses in dairy and beef herds. Bovela®is a vaccine that is designed to reduce some of the clinical signs typical for BVD, and to prevent the birth of so-called persistently infected animals caused by transplacental infection with BVDV. Vaccination with Bovela® is expected to provide protection within the herd against the disease and against the circulation of the virus.
The Pyramid® family of vaccines is providing a broad coverage against respiratory and reproductive diseases. The range consists of several antigen combinations suitable for the needs of the customer.
Indications | Brand Names | Active Ingredients | |
---|---|---|---|
Cattle infectious diseases Respiratory and reproductive diseases in cattle |
Pyramid® Presponse® |
Several multivalent vaccine combinations including modified live viruses: bovine viral diarrhea (BVD) Types 1 and 2, infectious bovine rhinotracheitis (IBR), parainfluenza 3 (PI3) and bovine respiratory syncytial virus (BRSV), and bacteria: Pasteurella multocida, Mannheimia haemolytica, L. canicola, L. grippotyphosa, L. hardjo, L. icterohaemmorrhagiae, and L. pomona. | ![]() |
Bovine Viral Diarrhoea | Bovela® |
modified live BVDV *-1 strain, modified live BVDV *-2 strain
* Bovine Viral Diarrhoea Virus |
![]() |